These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16928354)

  • 1. Mechanisms and models of alpha-synuclein-related neurodegeneration.
    Springer W; Kahle PJ
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):432-6. PubMed ID: 16928354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Synucleinopathy models and human neuropathology: similarities and differences.
    Kahle PJ
    Acta Neuropathol; 2008 Jan; 115(1):87-95. PubMed ID: 17932682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glia and alpha-synuclein in neurodegeneration: A complex interaction.
    Brück D; Wenning GK; Stefanova N; Fellner L
    Neurobiol Dis; 2016 Jan; 85():262-274. PubMed ID: 25766679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.
    Olsen AL; Feany MB
    Glia; 2019 Oct; 67(10):1933-1957. PubMed ID: 31267577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathological spectrum of synucleinopathies.
    Jellinger KA
    Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.
    Fellner L; Jellinger KA; Wenning GK; Stefanova N
    Acta Neuropathol; 2011 Jun; 121(6):675-93. PubMed ID: 21562886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
    Peng C; Gathagan RJ; Lee VM
    Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ɑ-Synuclein strains and the variable pathologies of synucleinopathies.
    Peelaerts W; Baekelandt V
    J Neurochem; 2016 Oct; 139 Suppl 1():256-274. PubMed ID: 26924014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein aggregation mechanisms in synucleinopathies: commonalities and differences.
    Beyer K; Ariza A
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):965-74. PubMed ID: 17984679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
    Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
    Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice.
    Rabl R; Breitschaedel C; Flunkert S; Duller S; Amschl D; Neddens J; Niederkofler V; Rockenstein E; Masliah E; Roemer H; Hutter-Paier B
    BMC Neurosci; 2017 Jan; 18(1):22. PubMed ID: 28143405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Mitochondrial Complex II-Dependent Respiration Is Beneficial for α-Synucleinopathies.
    Fröhlich C; Zschiebsch K; Gröger V; Paarmann K; Steffen J; Thurm C; Schropp EM; Brüning T; Gellerich F; Radloff M; Schwabe R; Lachmann I; Krohn M; Ibrahim S; Pahnke J
    Mol Neurobiol; 2016 Sep; 53(7):4728-44. PubMed ID: 26319560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
    Lee VM; Trojanowski JQ
    Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein misfolding and neurodegenerative diseases.
    Uversky VN
    Curr Protein Pept Sci; 2008 Oct; 9(5):507-40. PubMed ID: 18855701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease.
    Gou DH; Huang TT; Li W; Gao XD; Haikal C; Wang XH; Song DY; Liang X; Zhu L; Tang Y; Ding C; Li JY
    Redox Biol; 2021 Jan; 38():101795. PubMed ID: 33232911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy.
    Lopez-Cuina M; Guerin PA; Canron MH; Delamarre A; Dehay B; Bezard E; Meissner WG; Fernagut PO
    Mov Disord; 2020 Jul; 35(7):1163-1172. PubMed ID: 32291831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
    Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
    Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.